Abacavir Sulfate; Dolutegravir Sodium; Lamivudine Patent Expiration
Abacavir Sulfate; Dolutegravir Sodium; Lamivudine was first introduced by Viiv Healthcare Co
Abacavir Sulfate; Dolutegravir Sodium; Lamivudine Patents
Given below is the list of patents protecting Abacavir Sulfate; Dolutegravir Sodium; Lamivudine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Triumeq |
US9242986 (Pediatric) | Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates | Jun 08, 2030 | Viiv Hlthcare |
| Triumeq Pd |
US9242986 (Pediatric) | Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates | Jun 08, 2030 | Viiv Hlthcare |
| Triumeq | US9242986 | Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates | Dec 08, 2029 | Viiv Hlthcare |
| Triumeq Pd | US9242986 | Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates | Dec 08, 2029 | Viiv Hlthcare |
| Triumeq |
US8129385 (Pediatric) | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness | Apr 05, 2028 | Viiv Hlthcare |
| Triumeq Pd |
US8129385 (Pediatric) | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness | Apr 05, 2028 | Viiv Hlthcare |
| Triumeq | US8129385 | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness | Oct 05, 2027 | Viiv Hlthcare |
| Triumeq Pd | US8129385 | Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dioness | Oct 05, 2027 | Viiv Hlthcare |
| Triumeq |
US6294540 (Pediatric) | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
Nov 14, 2018
(Expired) | Viiv Hlthcare |
| Triumeq | US6294540 | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
May 14, 2018
(Expired) | Viiv Hlthcare |
| Triumeq |
US5905082 (Pediatric) | Crystalline oxathiolane derivatives |
Nov 18, 2016
(Expired) | Viiv Hlthcare |
| Triumeq |
US6417191 (Pediatric) | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Sep 28, 2016
(Expired) | Viiv Hlthcare |
| Triumeq | US5905082 | Crystalline oxathiolane derivatives |
May 18, 2016
(Expired) | Viiv Hlthcare |
| Triumeq | US6417191 | Synergistic combinations of zidovudine, 1592U89 and 3TC |
Mar 28, 2016
(Expired) | Viiv Hlthcare |
Abacavir Sulfate; Dolutegravir Sodium; Lamivudine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List